BPC-157 vs Thymosin Alpha-1 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
BPC-157 is a synthetic 15-amino acid peptide derived from gastric juice. It accelerates tissue repair, tendon healing, and gut protection via angiogenesis and growth hormone receptor upregulation. Orally bioavailable and stable in gastric acid. Extensive preclinical evidence acro...
Calculate BPC-157 dose →Thymosin Alpha-1 (TA1) is a 28-amino acid peptide naturally secreted by thymic epithelial cells, commercially available as Thymalfasin (Zadaxin). It is approved as a pharmaceutical drug in over 35 countries (including China, Italy, and Singapore) for chronic hepatitis B, chronic ...
Calculate Thymosin Alpha-1 dose →| Parameter | BPC-157 | Thymosin Alpha-1 |
|---|---|---|
| Category | Healing & Recovery | Immune Support |
| Research | Extensively Studied | Extensively Studied |
| Half-Life | 4–6 hours | ~2 hours |
| Typical Dose | 200–500 µg | 0.8–1.6 mg |
| Frequency | Once or twice daily | 2× weekly or daily |
| Route | Subcutaneous / Oral | Subcutaneous |
| FDA Status | Not Approved | Not Approved (US) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.